98%
921
2 minutes
20
Objectives: Percutaneous patent ductus arteriosus (PDA) stenting is a therapeutic modality in patients with duct-dependent pulmonary circulation with reported success rates from 80-100%. The current study aims to assess the outcome and the indicators of success for PDA stenting in different ductal morphologies using various approaches.
Methods: A prospective cohort study from a single tertiary center presented from January 2018 to December 2019 that included 96 consecutive infants with ductal-dependent pulmonary circulation and palliated with PDA stenting. Patients were divided according to PDA origin into 4 groups: Group 1: PDA from proximal descending aorta, Group 2: from undersurface of aortic arch, Group 3: opposite the subclavian artery, Group 4: opposite the innominate/brachiocephalic artery.
Results: The median age of patients was 22 days and median weight was 3 kg. The procedure was successful in 78 patients (81.25%). PDA was tortuous in 70 out of 96 patients. Femoral artery was the preferred approach in Group 1 (63/67), while axillary artery access was preferred in the other groups (6/11 in Group 2, 11/17 in Group 3, 1/1 in Group 4, P <0.0001). The main cause of procedural failure was inadequate parked coronary wire inside one of the branch of pulmonary arteries (14 cases; 77.7%), while 2 cases (11.1%) were complicated by acute stent thrombosis, and another 2 cases with stent dislodgment. Other procedural complications comprised femoral artery thrombosis in 7 cases (7.2%). Patients with straight PDA, younger age at procedure and who had larger PDA at pulmonary end had higher odds for success (OR = 8.01, 2.94, 7.40, CI = 1.011-63.68, 0.960-0.99, 1.172-7.40,respectively, P = 0.048, 0.031,0.022 respectively).
Conclusions: The approach for PDA stenting and hence the outcome is markedly determined by the PDA origin and morphology. Patients with straight PDA, younger age at procedure and those who had relatively larger PDA at the pulmonary end had better opportunity for successful procedure.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009684 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265031 | PLOS |
Gels
August 2025
School of Materials and Chemistry, University of Shanghai for Science and Technology, No. 334 Jungong Road, Shanghai 200093, China.
Pancreatic calculi, a common complication of chronic pancreatitis, significantly contribute to ductal obstruction, increased intraductal pressure, and debilitating abdominal pain. Although endoscopic pancreatic duct stenting alleviates ductal stenosis, conventional stents lack litholytic functionality, limiting their therapeutic efficacy. To address this challenge, we developed a drug-eluting pancreatic duct stent coated with a carboxymethyl chitosan methacrylate (CMCSMA)-based hydrogel utilizing 50% / citric acid (CA) as a litholytic agent.
View Article and Find Full Text PDFPediatr Rep
August 2025
Department of Pediatrics, Chungnam National University Sejong Hospital, School of Medicine, Chungnam National University, Daejeon 35105, Republic of Korea.
There are no recorded cases of catheter-induced aortic dissection in pediatric patients. We report a unique case of a pediatric patient with Down syndrome who developed a long-standing dissecting aortic aneurysm. The patient underwent successful stent insertion 10 years after experiencing difficulty retrieving an embolized patent ductus arteriosus device.
View Article and Find Full Text PDFAnn Thorac Surg
August 2025
Ward Family Heart Center, Children's Mercy Kansas City, MO, USA; University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Background: The management of Pulmonary Atresia with Ventricular Septal Defect (PA/VSD) without Major Aortopulmonary Collaterals (MAPCAs) varies widely, yet multicenter outcome data is limited. This study employs a multi-institutional database to explore practice patterns, treatment strategies, and outcomes.
Methods: We identified 304 patients with PA/VSD without MAPCAs from the Pediatric Health Information System database who underwent biventricular repair between January 1, 2003, and December 31, 2023.
World J Pediatr Congenit Heart Surg
July 2025
Department of Paediatric Cardiac Surgery, Alder Hey Children's Hospital, Liverpool, UK.
BackgroundMost Tetralogy of Fallot (TOF) patients undergo reparative surgery at approximately 6 months of age. However, some patients experience severe cyanotic spells in the neonatal or infancy period requiring urgent procedures to increase pulmonary blood flow.MethodsRetrospective review of patients younger than 3 months with TOF who needed interventions between 2015 and 2021.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
September 2025
Department of Paediatric Cardiology, Leeds Teaching Hospitals Trust, Leeds, UK.
We present two cases of stent fracture and stenosis after patent ductus arteriosus (PDA) stenting for palliation of congenital heart disease with duct dependent pulmonary circulation, resulting in clinical compromise and re-intervention with further stent placement. As interventionists undertake PDA stenting in increasingly complex and tortuous ductal morphology, awareness of this potentially serious complication will allow early detection and management to improve patient outcomes.
View Article and Find Full Text PDF